Efficacy and safety of subcutaneous interferon beta-1a in relapsing–remitting multiple sclerosis: Further outcomes from the IMPROVE study

Abstract Background The IMPROVE study demonstrated that the fetal bovine serum (FBS)- and human serum albumin (HSA)-free formulation of subcutaneous (sc) interferon (IFN) beta-1a had beneficial effects on the numbers of combined unique active magnetic resonance imaging (MRI) lesions in relapsing–rem...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the neurological sciences 2012-01, Vol.312 (1), p.97-101
Hauptverfasser:	De Stefano, Nicola, Sormani, Maria Pia, Stubinski, Bettina, Blevins, Gregg, Drulovic, Jelena S, Issard, Delphine, Shotekov, Penko, Gasperini, Claudio
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Efficacy Interferon beta-1a Magnetic resonance imaging Medical sciences Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Neurology Randomized controlled trial Relapsing–remitting multiple sclerosis Safety
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!